Aribio's Oral Dementia Drug Selected as 'Most Anticipated Dementia Treatment' by UK's GlobalData
Aribio announced on Jan. 9 that the British global data analysis and consulting firm GlobalData has selected its "AR1001" as an Alzheimer's disease treatment with high potential for future commercial success. On Jan. 1, GlobalData released …